GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biostar Pharmaceuticals Inc (OTCPK:BSPM) » Definitions » 6-1 Month Momentum %

Biostar Pharmaceuticals (Biostar Pharmaceuticals) 6-1 Month Momentum % : N/A% (As of Apr. 29, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Biostar Pharmaceuticals 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-04-29), Biostar Pharmaceuticals's 6-1 Month Momentum % is N/A%.

The industry rank for Biostar Pharmaceuticals's 6-1 Month Momentum % or its related term are showing as below:

BSPM's 6-1 Month Momentum % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.47
* Ranked among companies with meaningful 6-1 Month Momentum % only.

Competitive Comparison of Biostar Pharmaceuticals's 6-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Biostar Pharmaceuticals's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biostar Pharmaceuticals's 6-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biostar Pharmaceuticals's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Biostar Pharmaceuticals's 6-1 Month Momentum % falls into.



Biostar Pharmaceuticals  (OTCPK:BSPM) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biostar Pharmaceuticals  (OTCPK:BSPM) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Biostar Pharmaceuticals 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Biostar Pharmaceuticals's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biostar Pharmaceuticals (Biostar Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
No. 588 Shiji Xi Avenue, Shaanxi Province, Xianyang, CHN, 712046
Biostar Pharmaceuticals Inc through its subsidiaries involves in the development, manufacturing, and marketing of pharmaceutical products for a variety of diseases and conditions in the People's Republic of China where it generates most of its revenues. The company's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B. The current product line of the company also includes several other OTC products and approximately 15 prescription-based pharmaceuticals. Its products are derived from medicinal herbs that are either grown at its own facility or purchased from the suppliers.

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Headlines